HLB Co., Ltd.
028300
Rang in aandelen
#4138
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Aandeelprijs
$29.28
Marktkapitalisatie
$3.89B
Verandering (1 dag)
-1.40%
Verandering (1 jaar)
-8.45%
Land
KR
Handel HLB Co., Ltd. (028300)
Categorie
Healthcare
Winst voor HLB Co., Ltd. (028300)
Winst in Jun 2026 TTM: $-160.32M
Volgens de meest recente financiële verslagen van HLB Co., Ltd. bedraagt de huidige winst van het bedrijf $-160.32M. In 2023 behaalde het bedrijf een winst van $-164.38M, een daling ten opzichte van de winst van 2022, die $-62.61M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van HLB Co., Ltd. van 2012 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-160.32M | 115.74% |
| 2024 | $-74.31M | -54.79% |
| 2023 | $-164.38M | 162.55% |
| 2022 | $-62.61M | -27.09% |
| 2021 | $-85.87M | 12.36% |
| 2020 | $-76.43M | 43.17% |
| 2019 | $-53.38M | -540.23% |
| 2018 | $12.13M | -138.75% |
| 2017 | $-31.29M | 69.49% |
| 2016 | $-18.46M | -310.93% |
| 2015 | $8.75M | -632.68% |
| 2014 | $-1.64M | -80.80% |
| 2013 | $-8.56M | 40.17% |
| 2012 | $-6.11M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $5.27B | -3,390.24% |
US
|
|
| $-3.09B | 1,825.53% |
US
|
|
| $-4.02B | 2,405.12% |
AU
|
|
| $1.95B | -1,316.72% |
NL
|
|
| - | - |
CH
|
